Table 1.
Mass spectrometry analysis of HA-derived peptides from H1-VLP or soluble H1-treated MDMs obtained from four donors
| Parameters | Donor A | Donor B | Donor C | Donor D |
|---|---|---|---|---|
| HA treatment | Soluble H1 | – | Soluble H1 | Soluble H1 |
| Total protein amount, µg | 2397 | – | 1652 | 3272 |
| Sequence coverage (%) | 0 | – | 0 | 0 |
| Protein score | 0 | – | 0 | 0 |
| # MS/MS spectra | 0 | – | 0 | 0 |
| # Peptides | 0 | – | 0 | 0 |
| HA treatment | H1-VLPs | H1-VLPs | H1-VLPs | H1-VLPs |
| Total protein amount, µg | 2653 | 1444 | 2658 | 4340 |
| Sequence coverage (%) | 61 | 12 | 30 | 89 |
| Protein score | 32 | 75 | 152 | 323 |
| # MS/MS spectra | 29 | 11 | 16 | 84 |
| # Peptides | 25 | 10 | 14 | 66 |